Price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $2.62 to $2.65 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
Annual option grant as compensation for service on the board of directors. All options vested on the date of grant.
Annual option grant as compensation for service on the board of directors. Options vest as to 25% of total shares at the end of each fiscal quarter, becoming fully vested after one year.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever AxoGen, Inc. makes a similar move, sign up!